Deal Chad L
Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Curr Rheumatol Rep. 2007 Apr;9(1):66-70. doi: 10.1007/s11926-007-0024-z.
Clinical evaluation of patients with low bone mass attempts to determine which patients should be offered one of the effective therapies for fracture prevention. Current guidelines are primarily based on bone density. Risk factors are used, but their contribution to fracture risk is not easily assessed. The combination of bone density and risk factors can be used to assess absolute fracture risk, the risk of fracture over a period of time expressed as a percent. This model will allow identification of patients who would benefit most from treatment.
对低骨量患者进行临床评估，旨在确定哪些患者应接受预防骨折的有效治疗方法之一。目前的指南主要基于骨密度。虽然也会考虑风险因素，但其对骨折风险的影响并不容易评估。骨密度和风险因素相结合可用于评估绝对骨折风险，即在一段时间内骨折的风险，以百分比表示。该模型将有助于识别出最能从治疗中获益的患者。
